Exact Mass: 614.2641404
Exact Mass Matches: 614.2641404
Found 176 metabolites which its exact mass value is equals to given mass value 614.2641404,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Neomycin
C23H46N6O13 (614.3122705999999)
A component of neomycin that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. (From Merck Index, 11th ed). Neomycin is a bactericidal aminoglycoside antibiotic that binds to the 30S ribosome of susceptible organisms. Binding interferes with mRNA binding and acceptor tRNA sites and results in the production of non-functional or toxic peptides. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics B - Blood and blood forming organs > B05 - Blood substitutes and perfusion solutions > B05C - Irrigating solutions > B05CA - Antiinfectives D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AB - Antibiotics S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID N022
13(1)-Hydroxy-Mg-protoporphyrin IX 13-monomethyl ester
Bacteriochlorophyllide g
A chlorophyllide obtained by hydrolysis of the terpenoid ester moiety of bacteriochlorophyll g.
Harderoporphyrinogen
C35H42N4O6 (614.3104192000001)
Harderoporphyrinogen is an intermediate in the conversion of coproporphyrinogen III and protoporphyrinogen IX. An intermediate in the conversion of coproporphyrinogen III and protoporphyrinogen IX. [HMDB]
Neomycin sulfate
C23H46N6O13 (614.3122705999999)
4-[[(1R)-2-[[(2R)-2-(2-Adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid
C35H42N4O6 (614.3104192000001)
Tetraphenylporphyrin
131-hydroxy-magnesium-protoporphyrin IX 13-monomethyl ester
131-hydroxy-magnesium-protoporphyrin ix 13-monomethyl ester is a member of the class of compounds known as metalloporphyrins. Metalloporphyrins are polycyclic compounds containing a porphyrin moiety and a metal atom. 131-hydroxy-magnesium-protoporphyrin ix 13-monomethyl ester is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 131-hydroxy-magnesium-protoporphyrin ix 13-monomethyl ester can be found in a number of food items such as lambsquarters, wheat, sweet basil, and towel gourd, which makes 131-hydroxy-magnesium-protoporphyrin ix 13-monomethyl ester a potential biomarker for the consumption of these food products.
chrysoeriol 7-O-neohesperidoside
Isocalycopterone
Calycopterone
Neocalycopterone
Buddlenol C
A guaiacyl lignin that is syringaresinol in which one of the phenolic hydrogens is replaced by a guaiacylglycerol group. It is found in Arabidopsis thaliana.
131-oxo-magnesium-protoporphyrin IX 13-monomethyl ester
Divinyl chlorophyllide a; 3,8-Divinyl chlorophyllide a
13-acetyl-9-deacetyl-9-benzoyl-10-debenzoyltaxchinin A
Korksaeure-mono-<3>cinobufotalylester|Korksaeure-mono-[3]cinobufotalylester
(1S,3aR,3bS,4S,5aS,7aS,9R,13S,13aR,14aS,14bS,15aR)-13-(acetoxy)-1,3a,4,5,5a,6,7,9,11,12,13,13a,14,14b,15a-hexadecahydro-1,4,5a,11,11-pentamethyl-2,5,14-trioxo-2H,8H-7a,14a-epoxy-3,10,15-trioxaazuleno[6,5:5,6]cyclooct[1,2,3-cd]-as-indacene-9-acetic acid ethyl ester|wilsonianadilactone A
kandovanol ester A|rel-(1aR,3S,3aS,4S,4aS,5R,6R,7aS,9R,9aS,9bR)-3,5-bis(acetyloxy)-3a[(acetyloxy)methyl]-1a,2,3,3a,4,4a,5,6,7,7a,8,9a,9b-tetradecahydro-7a,9-dihydroxy-1,1,6,9-tetramethyl-8H-cyclopropa[3,4]benzo[1,2-f]azulen-8-one
Di-Me ester-Mesobiliverdin IXalpha
C35H42N4O6 (614.3104192000001)
6alpha,7alpha-epoxy-5beta-hydroxy-9,13,14-ortho-[(2E,4E)-deca-2,4-dien-1-yl]-resiniferonol-12beta-yl butanoate|yuanhualine
6-O-sec-hydroxyaeginetoyl ajugol|6-O-seco-hydroxyaeginetoyl ajugol
20-deoxy-13,16-dihydroxyingenol-13-acetate-3,16-dibenzoate
barlerin-6-hydroxy-2,6-dimethylocta-2,7-dienate ester
(?)-(7R,7R,7S,8S,8S,8S)-4,4-dihydroxy-3,3,3,5,5-pentamethoxy-7,9:7,9-diepoxy-4,8-oxy-8,8-sesquineolignan-7,9-diol
5,7,4-trihydroxy-2-nonyl-[2,3:2,3]-3-O-beta-D-galactopyranosyl furanoflavonoid|houttuynoid B
Di-Me ester-Mesobiliverdin IIIalpha
C35H42N4O6 (614.3104192000001)
3beta-detigloyoxy-isobutanoyloxy xylogranatin B|xylogranatin D
5,6,7-triacetoxy-3-benzoyloxy-14,15-dihydroxy-9-oxojatropha-6(17),11E-diene (8)
Neomycin C
C23H46N6O13 (614.3122705999999)
C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
His Ser Trp Trp
His Trp Ser Trp
His Trp Trp Ser
Asn Arg Tyr Tyr
Asn Tyr Arg Tyr
Asn Tyr Tyr Arg
Arg Asn Tyr Tyr
Arg Tyr Asn Tyr
Arg Tyr Tyr Asn
Ser His Trp Trp
Ser Trp His Trp
Ser Trp Trp His
Trp His Ser Trp
Trp His Trp Ser
Trp Ser His Trp
Trp Ser Trp His
Trp Trp His Ser
Trp Trp Ser His
Tyr Asn Arg Tyr
Tyr Asn Tyr Arg
Tyr Arg Asn Tyr
Tyr Arg Tyr Asn
Tyr Tyr Asn Arg
Tyr Tyr Arg Asn
4,4-[(3,3-dimethoxy[1,1-biphenyl]-4,4-diyl)bis(azo)]bis[2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one]
H-Gly-Arg-Gly-Asp-Asn-Pro-OH
RGD peptide (GRGDNP) is an inhibitor of integrin-ligand interactions. RGD peptide (GRGDNP) competitively inhibits α5β1 binding with extracellular matrice (ECM). RGD peptide (GRGDNP) promotes apoptosis through activation of conformation changes that enhance pro-caspase-3 activation and autoprocessing. RGD peptide (GRGDNP) plays an important role in cell adhesion, migration, growth, and differentiation[1][2][3].
[e]-5-(2-carbomethoxyvinyl)-5-o-(dimethoxytrityl)-2-deoxyuridine
5-Aminopentyl O-6-deoxy-alpha-L-galactopyranosyl-(1-3)-O-[beta-D-galactopyranosyl-(1-4)]-2-(acetylamino)-2-deoxy-beta-D-glucopyranoside
Fedratinib dihydrochloride monohydrate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor
chrysoeriol 7-O-neohesperidoside
4-[[(1R)-2-[[(2R)-2-(2-Adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid
C35H42N4O6 (614.3104192000001)
magnesium;3-[(21S,22S)-26-ethyl-16-[(1R)-1-hydroxyethyl]-12,17,21-trimethyl-11-(2-methylpropyl)-4-oxido-23,25-diaza-7,24-diazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1(23),2(6),3,5(26),8,10(25),11,13,15,17,19-undecaen-22-yl]propanoate
magnesium;3-[8,13-bis(ethenyl)-18-(1-hydroxy-3-methoxy-3-oxopropyl)-3,7,12,17-tetramethyl-23H-porphyrin-21-id-2-yl]propanoate
(-)-(7R,7R,7R,8S,8S,8S)-4,4-dihydroxy-3,3,3,5,5-pentamethoxy-7,9:7,9-diepoxy-4,8-oxy-8,8-sesquineolignan-7,9-diol
A neolignan isolated from the stems of Sinocalamus affinis.
(-)-(7R,7R,7S,8S,8S,8S)-4,4-dihydroxy-3,3,3,5,5-pentamethoxy-7,9:7,9-diepoxy-4,8-oxy-8,8-sesquineolignan-7,9-diol
A neolignan isolated from the stems of Sinocalamus affinis.
alpha-N-acetyllysine-N(6),N(6)-dimethyladenosine 5-phosphomorpholidate
(3S,4S)-3-[4-(hydroxymethyl)phenyl]-1-(3-methoxypropyl)-2-[[2-(trifluoromethyl)phenyl]methyl]spiro[3H-isoquinoline-4,3-4H-quinoline]-1,2-dione
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-[4-(trifluoromethyl)phenyl]urea
3-(2,4-dimethoxyphenyl)-1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea
C35H42N4O6 (614.3104192000001)
1-[(2R,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
3-(2,4-dimethoxyphenyl)-1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea
C35H42N4O6 (614.3104192000001)
3-(2,4-dimethoxyphenyl)-1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea
C35H42N4O6 (614.3104192000001)
3-(2,4-dimethoxyphenyl)-1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea
C35H42N4O6 (614.3104192000001)
1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
4,4,4-trifluoro-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
4,4,4-trifluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
4,4,4-trifluoro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
4,4,4-trifluoro-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(1-naphthalenylamino)-oxomethyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]butanamide
3-(2,4-dimethoxyphenyl)-1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea
C35H42N4O6 (614.3104192000001)
3-(2,4-dimethoxyphenyl)-1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea
C35H42N4O6 (614.3104192000001)
3-(2,4-dimethoxyphenyl)-1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-1-methylurea
C35H42N4O6 (614.3104192000001)
5-aminopentyl beta-D-glucopyranosyl-(1->3)-[alpha-L-rhamnopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-galactopyranoside
[3-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-2-nonanoyloxypropyl] nonanoate
[1-Heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] undecanoate
[1-Butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] tetradecanoate
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] tridecanoate
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] pentadecanoate
[1-Hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] dodecanoate
[1-[Hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-octanoyloxypropan-2-yl] decanoate
[1-Acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] hexadecanoate
[(2S,3aR,4S,5R,6E,13aR)-10,11,13-triacetyloxy-3a,4-dihydroxy-2,5,8,8-tetramethyl-12-methylidene-9-oxo-2,3,4,5,10,11,13,13a-octahydro-1H-cyclopenta[12]annulen-1-yl] benzoate
[(1S,2S,3aR,4S,5R,6E,13aR)-10,11,13-triacetyloxy-3a,4-dihydroxy-2,5,8,8-tetramethyl-12-methylidene-9-oxo-2,3,4,5,10,11,13,13a-octahydro-1H-cyclopenta[12]annulen-1-yl] benzoate
Framycetin
C23H46N6O13 (614.3122705999999)
A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics B - Blood and blood forming organs > B05 - Blood substitutes and perfusion solutions > B05C - Irrigating solutions > B05CA - Antiinfectives D - Dermatologicals > D09 - Medicated dressings > D09A - Medicated dressings > D09AA - Medicated dressings with antiinfectives D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use S - Sensory organs > S03 - Ophthalmological and otological preparations > S03A - Antiinfectives > S03AA - Antiinfectives R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials A tetracyclic antibacterial agent derived from neomycin, being a glycoside ester of neamine and neobiosamine B. R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AB - Antibiotics S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic